Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer

1 Apr 2024

Abstract excerpt

Lung cancer mortality is exacerbated by late-stage diagnosis. Emerging evidence indicates the potential clinical significance of distinct microbial signatures as diagnostic and prognostic biomarkers across various cancers. However, circulating microbiome DNA (cmDNA) profiles are underexplored in lung cancer (LC). Here, whole-genome sequencing is performed on plasma of LC patients and healthy controls (HCs)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genomics and Phylogenetic Studies
Share to Mycobacterium research and diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38582085
DOI: 10.1016/j.xcrm.2024.101499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancerPMID 38582085Read ↗

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read ↗

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read ↗

Microbial Biomarkers for Lung Cancer: Current Understandings and LimitationsSemantic proximity Read ↗

Microbial biomarker development for detection and prognosis of early-stage non-small cell lung cancerSemantic proximity Read ↗

Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage AdenocarcinomaSemantic proximity Read ↗

Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokersSemantic proximity Read ↗

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early DetectionSemantic proximity Read ↗

Specific gut microbiome signature predicts the early-stage lung cancerSemantic proximity Read ↗

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.Semantic proximity Read ↗

The characteristics of intratumoral microbial community reflect the development of lung adenocarcinomaSemantic proximity Read ↗

Human Microbiome as Clinical Biomarkers for Respiratory Tract CancersSemantic proximity Read ↗

The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.